BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

MAbSilico

MAbSilico logo

Founded
2017
Publications
6

Technologies

AI Companies (Drug Discovery)

MAbSilico is a deeptech company from French academic research labs. Founded in 2017, MAbSilico is a software editor with the vision to accelerate the development of therapeutic antibody focusing on the early stage development to provide leads in a few years today to a few weeks.

MAbSilico is developing a software suite combining algorithms and databases based on 20 years of proven research and protected by patent. Our Artificial Intelligence and machine learning -driven tools cover two key steps of the early-stage antibody development; the lead identification and the lead characterization.

Become a Member to view additional information about this company